Genetic engineering approach to develop next-generation reagents for endotoxin quantification
Autor: | Norihiko Ogura, Shun Ichiro Kawabata, Hikaru Mizumura, Jun Aketagawa, Yuki Kobayashi, Maki Aizawa, Toshio Oda |
---|---|
Rok vydání: | 2016 |
Předmět: |
Cell Extracts
Amoebocyte lysate reagent 0301 basic medicine Amebocyte endotoxin Lysis Glycosylation medicine.medical_treatment Immunology Biology Sensitivity and Specificity Microbiology Complement factor B mammalian cell law.invention 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine law horseshoe crab Endopeptidases Horseshoe Crabs medicine Animals recombinant cascade reagent Molecular Biology Limulus Test Enzyme Precursors Protease Serine Endopeptidases Original Articles Cell Biology Reference Standards biology.organism_classification Molecular biology Recombinant Proteins Horseshoe crab Endotoxins 030104 developmental biology Infectious Diseases chemistry Reagent Recombinant DNA Insect Proteins Indicators and Reagents Genetic Engineering Complement Factor B 030215 immunology |
Zdroj: | Innate Immunity |
ISSN: | 1753-4267 1753-4259 |
DOI: | 10.1177/1753425916681074 |
Popis: | The bacterial endotoxin test, which uses amebocyte lysate reagents of horseshoe crab origin, is a sensitive, reproducible and simple assay to measure endotoxin concentration. To develop sustainable raw materials for lysate reagents that do not require horseshoe crabs, three recombinant protease zymogens (factor C, derived from mammalian cells; factor B; and the proclotting enzyme derived from insect cells) were prepared using a genetic engineering technique. Recombinant cascade reagents (RCRs) were then prepared to reconstruct the reaction cascade in the amebocyte lysate reagent. The protease activity of the RCR containing recombinant factor C was much greater than that of recombinant factor C alone, indicating the efficiency of signal amplification in the cascade. Compared with the RCR containing the insect cell-derived factor C, those containing mammalian cell-derived factor C, which features different glycosylation patterns, were less susceptible to interference by the injectable drug components. The standard curve of the RCR containing mammalian cell-derived recombinant factor C had a steeper slope than the curves for those containing natural lysate reagents, suggesting a greater sensitivity to endotoxin. The present study supports the future production of recombinant reagents that do not require the use of natural resources. |
Databáze: | OpenAIRE |
Externí odkaz: |